The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1225
A Combination of Oxycodone and Ibuprofen (Combunox) for Pain
The full article is available to subscribers Subscriber Login   

A fixed-dose combination of oxycodone 5 mg and ibuprofen 400 mg (Combunox – Forest Laboratories) is now available and is being heavily advertised for short-term treatment of moderate to severe acute pain.

THE DRUGSOxycodone is a semisynthetic opioid analgesic structurally related to morphine and codeine. It is about 1.5 times more potent than hydrocodone and 7.0-9.5 times more potent than oral codeine for relief of pain. Single-entity oxycodone is available in the US as immediate-release and controlled-release tablets (Oxycontin) and in liquid formulations. Oral oxycodone has been available in the US since the 1950’s in combination with aspirin (Percodan) or acetaminophen (Percocet, and others).

Ibuprofen, a nonselective nonsteroidal anti-inflammatory drug (NSAID), is available by prescription and in lower-strength over-the-counter formulations. A 400-mg dose ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Combination of Oxycodone and Ibuprofen (Combunox) for Pain
Article code: 1225b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian